Which has stronger valuation & earnings, RVT or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Royce Small-Cap Trust N/A N/A N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.04 N/A N/A N/A

Is RVT or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Royce Small-Cap Trust N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Does the media refer more to RVT or HQL?

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Royce Small-Cap Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Royce Small-Cap Trust. Royce Small-Cap Trust's average media sentiment score of 1.91 beat abrdn Life Sciences Investors' score of 1.07 indicating that Royce Small-Cap Trust is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Royce Small-Cap Trust 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, NUV or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nuveen Municipal Value Fund N/A N/A N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.04 N/A N/A N/A

Is NUV or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Nuveen Municipal Value Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has preferable valuation and earnings, USA or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Liberty All-Star Equity Fund N/A N/A N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.04 N/A N/A N/A

Is USA or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Liberty All-Star Equity Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Does the media refer more to USA or HQL?

In the previous week, Liberty All-Star Equity Fund and Liberty All-Star Equity Fund both had 4 articles in the media. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Liberty All-Star Equity Fund's score of 0.71 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liberty All-Star Equity Fund 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, GAB or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gabelli Equity Trust $305.25M 5.79 N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.04 N/A N/A N/A

Is GAB or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Gabelli Equity Trust N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has stronger earnings & valuation, STEW or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SRH Total Return Fund N/A N/A N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.04 N/A N/A N/A

Is STEW or HQL more profitable?

Company Net Margins Return on Equity Return on Assets SRH Total Return Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Does the media refer more to STEW or HQL?

In the previous week, abrdn Life Sciences Investors had 2 more articles in the media than SRH Total Return Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 2 mentions for SRH Total Return Fund. SRH Total Return Fund's average media sentiment score of 1.43 beat abrdn Life Sciences Investors' score of 1.07 indicating that SRH Total Return Fund is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SRH Total Return Fund 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

abrdn Life Sciences Investors (HQL) Competitors

$19.92 -0.01 (-0.03%)

As of 01:30 PM Eastern

Compare

HQL vs. RVT, NUV, USA, GAB, and STEW

Should you buy abrdn Life Sciences Investors stock or one of its competitors? MarketBeat compares abrdn Life Sciences Investors with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with abrdn Life Sciences Investors include Royce Small-Cap Trust (RVT), Nuveen Municipal Value Fund (NUV), Liberty All-Star Equity Fund (USA), Gabelli Equity Trust (GAB), and SRH Total Return Fund (STEW). These companies are all part of the "financial services" industry.

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Royce Small-Cap Trust (NYSE:RVT) and abrdn Life Sciences Investors (NYSE:HQL) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Royce Small-Cap Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Royce Small-Cap Trust. Royce Small-Cap Trust's average media sentiment score of 1.91 beat abrdn Life Sciences Investors' score of 1.07 indicating that Royce Small-Cap Trust is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Royce Small-Cap Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

25.6% of Royce Small-Cap Trust shares are owned by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 0.1% of Royce Small-Cap Trust shares are owned by company insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Royce Small-Cap Trust has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Royce Small-Cap Trust	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.04	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Royce Small-Cap Trust	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Royce Small-Cap Trust pays an annual dividend of $1.44 per share and has a dividend yield of 8.0%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.3%.

Summary

abrdn Life Sciences Investors beats Royce Small-Cap Trust on 5 of the 7 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Nuveen Municipal Value Fund (NYSE:NUV) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

22.5% of Nuveen Municipal Value Fund shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 1.0% of Nuveen Municipal Value Fund shares are held by company insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuveen Municipal Value Fund	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.04	N/A	N/A	N/A

Nuveen Municipal Value Fund pays an annual dividend of $0.19 per share and has a dividend yield of 2.1%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.3%.

Company	Net Margins	Return on Equity	Return on Assets
Nuveen Municipal Value Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Nuveen Municipal Value Fund has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Nuveen Municipal Value Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Nuveen Municipal Value Fund. Nuveen Municipal Value Fund's average media sentiment score of 1.21 beat abrdn Life Sciences Investors' score of 1.07 indicating that Nuveen Municipal Value Fund is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuveen Municipal Value Fund	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

abrdn Life Sciences Investors beats Nuveen Municipal Value Fund on 6 of the 7 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Liberty All-Star Equity Fund (NYSE:USA) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

10.0% of Liberty All-Star Equity Fund shares are owned by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 0.1% of Liberty All-Star Equity Fund shares are owned by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Liberty All-Star Equity Fund has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Liberty All-Star Equity Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liberty All-Star Equity Fund	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.04	N/A	N/A	N/A

In the previous week, Liberty All-Star Equity Fund and Liberty All-Star Equity Fund both had 4 articles in the media. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Liberty All-Star Equity Fund's score of 0.71 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liberty All-Star Equity Fund	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Liberty All-Star Equity Fund pays an annual dividend of $0.68 per share and has a dividend yield of 11.4%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.3%.

Summary

abrdn Life Sciences Investors beats Liberty All-Star Equity Fund on 4 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

Gabelli Equity Trust (NYSE:GAB) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Gabelli Equity Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 3 mentions for Gabelli Equity Trust. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Gabelli Equity Trust's score of 0.49 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gabelli Equity Trust	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Gabelli Equity Trust has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

Gabelli Equity Trust pays an annual dividend of $0.60 per share and has a dividend yield of 10.6%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.3%.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gabelli Equity Trust	$305.25M	5.79	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.04	N/A	N/A	N/A

7.2% of Gabelli Equity Trust shares are owned by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 0.8% of Gabelli Equity Trust shares are owned by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Gabelli Equity Trust	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Summary

abrdn Life Sciences Investors beats Gabelli Equity Trust on 5 of the 8 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

SRH Total Return Fund (NYSE:STEW) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

SRH Total Return Fund has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

15.6% of SRH Total Return Fund shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 0.1% of SRH Total Return Fund shares are held by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
SRH Total Return Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

SRH Total Return Fund pays an annual dividend of $0.73 per share and has a dividend yield of 4.0%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.3%.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SRH Total Return Fund	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.04	N/A	N/A	N/A

In the previous week, abrdn Life Sciences Investors had 2 more articles in the media than SRH Total Return Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 2 mentions for SRH Total Return Fund. SRH Total Return Fund's average media sentiment score of 1.43 beat abrdn Life Sciences Investors' score of 1.07 indicating that SRH Total Return Fund is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SRH Total Return Fund	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

abrdn Life Sciences Investors beats SRH Total Return Fund on 5 of the 7 factors compared between the two stocks.

Get abrdn Life Sciences Investors News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQL vs. The Competition

Export

Metric	abrdn Life Sciences Investors	FIN Industry	Finance Sector	NYSE Exchange
Market Cap	$604.82M	$4.82B	$14.41B	$23.41B
Dividend Yield	10.26%	6.87%	5.70%	4.02%
P/E Ratio	N/A	0.02	20.64	31.23
Price / Sales	3.04	23.50	44.52	19.73
Price / Cash	N/A	4.79	19.32	24.90
Price / Book	N/A	3.06	2.27	4.79
Net Income	N/A	$388.27M	$1.13B	$1.07B
7 Day Performance	-3.52%	0.10%	1.30%	1.11%
1 Month Performance	16.02%	0.14%	1.61%	0.56%
1 Year Performance	53.59%	11.66%	13.97%	18.53%

abrdn Life Sciences Investors Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQL abrdn Life Sciences Investors	N/A	$19.92 0.0%	N/A	+51.5%	$605.58M	$198.93M	N/A	N/A	News Coverage Positive News Short Interest Decrease
RVT Royce Small-Cap Trust	N/A	$17.88 -1.6%	N/A	+17.5%	$2.14B	N/A	N/A	50	Positive News
NUV Nuveen Municipal Value Fund	N/A	$9.17 -0.5%	N/A	+6.0%	$1.93B	N/A	N/A	640	News Coverage Positive News
USA Liberty All-Star Equity Fund	N/A	$5.85 -0.6%	N/A	-13.1%	$1.80B	N/A	N/A	N/A	News Coverage Short Interest Increase
GAB Gabelli Equity Trust	N/A	$5.62 -0.4%	N/A	-3.7%	$1.75B	N/A	N/A	N/A	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HQL) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, NUV, USA, GAB, and STEW

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Summary

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

Summary

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, NUV, USA, GAB, and STEW

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Does the media refer more to RVT or HQL?

Do institutionals and insiders hold more shares of RVT or HQL?

Which has more volatility & risk, RVT or HQL?

Which has stronger valuation & earnings, RVT or HQL?

Is RVT or HQL more profitable?

Is RVT or HQL a better dividend stock?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Do institutionals and insiders have more ownership in NUV or HQL?

Which has better valuation and earnings, NUV or HQL?

Is NUV or HQL a better dividend stock?

Is NUV or HQL more profitable?

Which has more risk and volatility, NUV or HQL?

Does the media prefer NUV or HQL?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Do insiders & institutionals hold more shares of USA or HQL?

Which has more volatility & risk, USA or HQL?

Is USA or HQL more profitable?

Which has preferable valuation and earnings, USA or HQL?

Does the media refer more to USA or HQL?

Is USA or HQL a better dividend stock?

Summary

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

Does the media refer more to GAB or HQL?

Which has more risk & volatility, GAB or HQL?

Is GAB or HQL a better dividend stock?

Which has stronger valuation and earnings, GAB or HQL?

Do institutionals & insiders have more ownership in GAB or HQL?

Is GAB or HQL more profitable?

Summary

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

Which has more risk and volatility, STEW or HQL?

Do insiders and institutionals believe in STEW or HQL?

Is STEW or HQL more profitable?

Is STEW or HQL a better dividend stock?

Which has stronger earnings & valuation, STEW or HQL?

Does the media refer more to STEW or HQL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools